COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
Rikke Boedker HolmstroemOle Haagen NielsenSøren JacobsenLene Buhl RiisSusann TheileJacob Tveiten BjerrumPeter VilmannJulia Sidenius JohansenMogens Karsbøl BoisenRikke Helene Løvendahl EefsenInge Marie SvaneDorte Lisbet NielsenInna Markovna ChenPublished in: Journal for immunotherapy of cancer (2022)
NCT03601611.